Beyond GLP-1 Multi-modal metabolic care: GLP-1 plus hormone optimization, IV recovery, and advanced peptide protocols
To overcome this limitation, scientists have developed GLP-1 receptor agonists (GLP-1 RAs), such as semaglutide, tilpotide, etc., which extend the half-life to the weekly formulation level through structural modification, achieving sustained regulation
Published literature frames BPC-157 research largely through preclinical and in vitro models
The human doses were converted to mouse-equivalent doses using a standard adult human body weight of 60 kg, resulting in the following dosages: 0.00166 g/kg/day for glutathione, 0.00666 g/kg/day for Ganoderma lucidum extract, and 0.00666 g/kg/day for vitamin C
JAMA 327 , 534545 (2022) M.J
Abstract Ferroptosis is an iron-dependent, lipid peroxidation-driven cell death pathway, while Parkinsons disease (PD) patients exhibit iron deposition and lipid peroxidation in the brain